As of May 22
| +0.0049 / +0.99%|
The 2 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 4.63, with a high estimate of 5.00 and a low estimate of 4.25. The median estimate represents a +825.00% increase from the last price of 0.50.
The current consensus among 2 polled investment analysts is to Buy stock in Rxi Pharmaceuticals Corp. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.